Warby Parker (WRBY) Stock Forecast & Price Target

$21.12 -0.11 (-0.52%)

(As of 11/13/2024 ET)

Warby Parker - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 12 Analyst Ratings

Sell
0

Hold
4

Buy
8

Based on 12 Wall Street analysts who have issued ratings for Warby Parker in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 12 analysts, 4 have given a hold rating, and 8 have given a buy rating for WRBY.

Consensus Price Target

$18.18
-13.91% Downside

According to the 12 analysts' twelve-month price targets for Warby Parker, the average price target is $18.18. The highest price target for WRBY is $23.00, while the lowest price target for WRBY is $14.00. The average price target represents a forecasted downside of -13.91% from the current price of $21.12.

WRBY Analyst Ratings Over Time

Type	Current Forecast 11/15/23 to 11/14/24	1 Month Ago 10/16/23 to 10/15/24	3 Months Ago 8/17/23 to 8/16/24	1 Year Ago 11/15/22 to 11/15/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	8 Buy rating(s)	3 Buy rating(s)	3 Buy rating(s)	5 Buy rating(s)
Hold	4 Hold rating(s)	4 Hold rating(s)	4 Hold rating(s)	5 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$18.18	$16.71	$16.57	$17.20
Forecasted Upside	-13.91% Downside	6.87% Upside	14.36% Upside	50.61% Upside
Consensus Rating	Moderate Buy	Hold	Hold	Moderate Buy

“This Changes Everything” - Trump Hands Millions Massive IRS Gift (Ad)

Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…

>> YES! Send Me My FREE Gold Guide!

WRBY Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

WRBY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Warby Parker Stock vs. The Competition

Type	Warby Parker	Medical Companies	S&P 500
Consensus Rating Score	2.67	2.80	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Hold
Predicted Upside	-13.91% Downside	26,278.21% Upside	8.03% Upside
News Sentiment Rating	Neutral News See Recent WRBY News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
11/8/2024	Piper Sandler 2 of 5 stars		Boost Target	Overweight ➝ Overweight	$18.00 ➝ $22.00	+13.29%
11/8/2024	Robert W. Baird 2 of 5 stars		Boost Target	Outperform ➝ Outperform	$18.00 ➝ $23.00	+19.11%
11/7/2024	William Blair 2 of 5 stars	D. Carden Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Market Perform ➝ Outperform
11/7/2024	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$19.00 ➝ $19.00	+0.18%
11/1/2024	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$18.00 ➝ $20.00	+13.70%
10/21/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Roach Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$15.00 ➝ $18.00	+8.76%
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad) Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics… Get Your Free Gold Guide
10/21/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Neutral ➝ Buy	$15.00 ➝ $18.00	+8.76%
8/23/2024	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	N. Jones Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Market Perform ➝ Outperform	$20.00	+44.30%
8/9/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$14.00 ➝ $15.00	+6.99%
7/10/2024	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$15.00 ➝ $16.00	+1.65%
5/10/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$13.00 ➝ $15.00	+0.07%
5/10/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$13.00 ➝ $14.00	-7.59%
10/3/2023	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	In-Line ➝ Outperform	$20.00	+50.77%
8/11/2023	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$13.00 ➝ $14.00	+4.48%
3/1/2023	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$23.00 ➝ $17.00	+30.67%
12/15/2022	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Outperform	$20.00	+28.70%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 01:43 AM ET.

WRBY Forecast - Frequently Asked Questions

: According to the research reports of 12 Wall Street equities research analysts, the average twelve-month stock price forecast for Warby Parker is $18.18, with a high forecast of $23.00 and a low forecast of $14.00.
: 12 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Warby Parker in the last twelve months. There are currently 4 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" WRBY shares.
: According to analysts, Warby Parker's stock has a predicted downside of -13.91% based on their 12-month stock forecasts.
: Over the previous 90 days, Warby Parker's stock had 4 upgrades by analysts.
: Warby Parker has been rated by research analysts at BTIG Research, Deutsche Bank Aktiengesellschaft, JMP Securities, Piper Sandler, Robert W. Baird, Telsey Advisory Group, The Goldman Sachs Group, and William Blair in the past 90 days.
: Analysts like Warby Parker less than other "medical" companies. The consensus rating score for Warby Parker is 2.67 while the average consensus rating score for "medical" companies is 2.80. Learn more on how WRBY compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

The Crypto That’s Making Wall Street Sweat (Ad)

The Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech giants are quietly integrating it. Venture capitalists are scrambling to invest.

Click here to discover our #1 crypto for the market right now – poised for massive growth

This page (NYSE:WRBY) was last updated on 11/14/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

Get Started with MarketBeat

	Read Your Daily Newsletter
	Check Out My MarketBeat
	Watch Our Tutorial Videos
	Add a Stock to Your Watchlist
	Set Up an Instant Alert
	View a Company's Profile Page
	View Our Financial Calendars
	View Today's Analyst Ratings

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Warby Parker (WRBY) Stock Forecast & Price Target